Picture of Kilitch Drugs (India) logo

KILITCH Kilitch Drugs (India) Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Kilitch Drugs (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line16.151.296.1120194
Depreciation
Non-Cash Items-39.48.1314.362.485
Unusual Items
Other Non-Cash Items
Changes in Working Capital40.8377-77.3-192-313
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities37.545757.825.9-1.46
Capital Expenditures-105-363-82-38.1-64.5
Purchase of Fixed Assets
Other Investing Cash Flow Items0.453-12.7-70.5117-30.9
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-105-376-15379.2-95.4
Financing Cash Flow Items1.22-6.4156.4-49.8-45
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities15.716.170.3-7.1688.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-51.497-24.497.8-8.84